Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Short-read Sequencing Market Trends and Forecast
3.3: Global Short-read Sequencing Market by Product
3.3.1: Instruments
3.3.2: Consumables
3.3.3: Services
3.4: Global Short-read Sequencing Market by Technology
3.4.1: Next-Generation Sequencing
3.4.2: Sanger Sequencing
3.5: Global Short-read Sequencing Market by Workflow
3.5.1: Pre-Sequencing
3.5.2: Sequencing
3.5.3: Data Analysis
3.6: Global Short-read Sequencing Market by Application
3.6.1: Oncology
3.6.2: Clinical Investigation
3.6.3: Reproductive Health
3.6.4: HLA Typing/Immune System Monitoring
3.6.5: Metagenomics
3.6.6: Epidemiology & Drug Development
3.6.7: Agrigenomics & Forensics
3.6.8: Consumer Genomics
3.7: Global Short-read Sequencing Market by End Use
3.7.1: Academic Research
3.7.2: Clinical Research
3.7.3: Hospitals & Clinics
3.7.4: Pharma & Biotech Entities
3.7.5: Others
4. Market Trends and Forecast Analysis by Region
4.1: Global Short-read Sequencing Market by Region
4.2: North American Short-read Sequencing Market
4.2.1: Market by Product: Instruments, Consumables, and Services
4.2.2: Market by Technology: Next-Generation Sequencing and Sanger Sequencing
4.2.3: Market by Workflow: Pre-Sequencing, Sequencing, and Data Analysis
4.2.4: Market by Application: Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, and Consumer Genomics
4.2.5: Market by End Use: Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others
4.2.6: The United States Short-read Sequencing Market
4.2.7: The Canadian Short-read Sequencing Market
4.2.8: The Mexican Short-read Sequencing Market
4.3: European Short-read Sequencing Market
4.3.1: Market by Product: Instruments, Consumables, and Services
4.3.2: Market by Technology: Next-Generation Sequencing and Sanger Sequencing
4.3.3: Market by Workflow: Pre-Sequencing, Sequencing, and Data Analysis
4.3.4: Market by Application: Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, and Consumer Genomics
4.3.5: Market by End Use: Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others
4.3.6: The Short-read Sequencing Market of United Kingdom
4.3.7: The German Short-read Sequencing Market
4.3.8: The French Short-read Sequencing Market
4.4: APAC Short-read Sequencing Market
4.4.1: Market by Product: Instruments, Consumables, and Services
4.4.2: Market by Technology: Next-Generation Sequencing and Sanger Sequencing
4.4.3: Market by Workflow: Pre-Sequencing, Sequencing, and Data Analysis
4.4.4: Market by Application: Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, and Consumer Genomics
4.4.5: Market by End Use: Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others
4.4.6: The Chinese Short-read Sequencing Market
4.4.7: The Indian Short-read Sequencing Market
4.4.8: The Japanese Short-read Sequencing Market
4.5: ROW Short-read Sequencing Market
4.5.1: Market by Product: Instruments, Consumables, and Services
4.5.2: Market by Technology: Next-Generation Sequencing and Sanger Sequencing
4.5.3: Market by Workflow: Pre-Sequencing, Sequencing, and Data Analysis
4.5.4: Market by Application: Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, and Consumer Genomics
4.5.5: Market by End Use: Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, and Others
4.5.6: Brazilian Short-read Sequencing Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Short-read Sequencing Market by Product
7.1.2: Growth Opportunities for the Global Short-read Sequencing Market by Technology
7.1.3: Growth Opportunities for the Global Short-read Sequencing Market by Workflow
7.1.4: Growth Opportunities for the Global Short-read Sequencing Market by Application
7.1.5: Growth Opportunities for the Global Short-read Sequencing Market by End Use
7.1.6: Growth Opportunities for the Global Short-read Sequencing Market by Region
7.2: Emerging Trends in the Global Short-read Sequencing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Short-read Sequencing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Short-read Sequencing Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Thermo Fisher Scientific Inc.
8.2: Hoffmann-La Roche AG
8.3: Qiagen N.V.
8.4: Illumina, Inc.
8.5: Genewiz
8.6: Genscript Biotech Corporation
8.7: 10x Genomics
8.8: Macrogen, Inc.
8.9: Agilent Technologies
8.10: BGI Genomics